Literature DB >> 36207626

Patient education for breast cancer-related lymphedema: a systematic review.

Marisa Perdomo1, Claire Davies2, Kimberly Levenhagen3, Kathryn Ryans4, Laura Gilchrist5.   

Abstract

PURPOSE: The aim was to identify the impact of the (a) components of breast cancer-related lymphedema (BCRL) educational content, (b) modes of education, and (c) timing of education on arm volume, quality of life, function, complications associated with BCRL, adherence to interventions, and knowledge acquisition in individuals diagnosed with breast cancer (BC).
METHODS: This review followed the Preferred Reported Items for Systematic Review and Meta-analysis (PRISMA) guidelines (PROSPERO CRD42021253084). Databases searched included PubMed, CINAHL, Web of Science, Google Scholar, and Scopus from January 2010 to December 2021. Study quality and bias were assessed using the American Physical Therapy Association's Critical Appraisal Tool for Experimental Intervention Studies.
RESULTS: Forty-five studies were eligible, and 15 met the inclusion criteria (4 acceptable and 11 low quality). This review was unable to determine the optimal content, mode, and timing for BCRL education across survivorship. Content included a brief overview of BCRL, early signs and symptoms, risk reduction practices, and a point of contact. Delivery was multi-modal, and knowledge acquisition was rarely assessed. Education was provided pre/post operatively and after BCRL developed.
CONCLUSIONS: Individualized BCRL education via a multi-modal approach, repeated at multiple time points, and assessment of survivors' knowledge acquisition is recommended. Consideration of the survivors' phase of treatment, content volume, and time required to complete the program is advised when developing the educational intervention. IMPLICATIONS FOR CANCER SURVIVORS: Survivors of BC may need to advocate for BCRL education based on their individual risk and needs, request a point of contact for questions/follow up, and express their preferred style of learning.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Breast cancer; Lymphedema; Patient education; Survivorship; Systematic review

Year:  2022        PMID: 36207626      PMCID: PMC9546750          DOI: 10.1007/s11764-022-01262-4

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.062


Introduction

Breast cancer–related lymphedema (BCRL) impacts approximately 19% of survivors of breast cancer (BC), most commonly within the first 2 years after treatment [1, 2]. Individuals who develop lymphedema often demonstrate upper quadrant functional impairments, decreased participation in social activities, higher medical costs, and a lower quality of life [1-7]. Additionally, the impact of BCRL may result in a myriad of psychosocial responses, such as high levels of anxiety, depression, uncertainty, and lower self-esteem that occur throughout survivorship [8]. Due to the negative impact of BCRL, an educational intervention has the potential to increase the individual’s awareness of risk factors, early signs and symptoms, and treatment options that could lead to earlier detection and better control of BCRL [9-11]. Once BCRL does develop, education is also needed on skin hygiene, prevention of infection, and self-care practices. Healthcare professionals and those diagnosed with BC agree patient education is a key component of both prevention and treatment of BCRL; however, individuals diagnosed with BC report having inadequate knowledge about lymphedema and its sequela across the trajectory of survivorship [12-14]. A contributing factor may be the lack of guidance for healthcare professionals when developing an educational intervention throughout survivorship [15]. The goal of this systematic review was to evaluate the available evidence on BCRL education for individuals at risk and those who have developed the condition and to identify gaps in the literature to direct future research. The primary aim of this systematic review is to identify the impact of the different (a) components of BCRL educational content, (b) modes of education, and (c) timing of educational intervention across the trajectory of BC care. The secondary aim is to examine the effect of patient education on arm volume, quality of life, function, complications associated with BCRL, adherence to interventions, and knowledge acquisition in individuals diagnosed with BC.

Methodology

Study design and search strategy

This systematic review (PROSPERO registration number: CRD42021253084) was conducted following the Preferred Reported Items for Systematic Review and Meta-analysis (PRISMA) guidelines. A literature search with the assistance of an academic librarian from the University of Southern California using the timeframe from January 1, 2011 to December 31, 2021 was conducted. Electronic databases searched included PubMed, CINAHL, Web of Science, Google Scholar, and Scopus. The final search terms were Lymphedema, Elephantiasis, and truncated text words lymphedema*, lymphoedema*, elephantiasis, patient education, risk reduction practices, precautions, prospective surveillance, and BC. Two independent reviewers screened the title and abstracts and applied the inclusion and exclusion criteria. Inclusion criteria included the following: quantitative study design; adults ≥ 18 years old; BC, at risk or with secondary lymphedema; education as an intervention; one measure related to quality of life, function, volume measures, adherence, complications, knowledge assessment, and English language studies only. Exclusion criteria included the following: case reports, case series, qualitative study design, literature reviews, editorial, letter, presentations, dissertations, and comments; studies including the terms filariasis, parasites, congenital, hereditary; adolescents < 18 years old, primary lymphedema; other cancer-related lymphedema; other causes of secondary lymphedema; lower extremity lymphedema; pelvic or genital lymphedema, and animal studies (Fig. 1).
Fig. 1

PRISMA flow chart illustrating the inclusion and quality rating of studies reviewed

PRISMA flow chart illustrating the inclusion and quality rating of studies reviewed

Quality appraisal

Study quality was assessed using the American Physical Therapy Association’s (APTA) Critical Appraisal Tool for Experimental Intervention Studies (CAT-EI). [16]. The CAT-EI assesses bias risk in clinical research and was used to assign a quality rating. Two reviewers independently appraised 3 studies to establish a quality rating agreement. The same reviewers then independently appraised the remaining studies and if quality-rating consensus did not agree, a third reviewer was used. The quality level rating was based on the APTA Clinical Practice Guideline recommendations [16]. The reviewers followed the recommendations for the APTA CAT-EI manual for determining quality ratings. The review group agreed upon the following essential scoring criteria that need to be met with a “YES” answer in order to be assigned a quality rating [16]. The following questions were utilized from the CAT-EI: Was the patient population appropriate for the study question? Was the study a randomized control trial? Did the sample size meet power requirements for the outcome of interest? Was the tester and/or data collector blinded to the treatment group of interest? For each outcome of interest, was a measure chosen that had established validity? For each outcome of interest, was a measure chosen that had established reliability? Were the appropriate statistical analysis chosen (e.g., subjects analyzed in the groups to which they were assigned)? Was their adequate follow-up (at least 1 month for intervention studies)? If the study met all 8 of the essential scoring items by 2 independent reviewers, the study received a “high-quality rating.” For an acceptable quality rating, the study needs to meet 6 of the 8 criteria. Likewise, a low-quality rating score was assigned if the study met between 2 and 5 of the criteria. Finally, an unacceptable quality rating was assigned to those studies scoring 0–1. The evidence for BCRL patient education as an intervention was appraised and synthesized. The extracted data included (a) the components of BCRL educational content, (b) modes of education, and (c) timing of educational intervention (Table 1).
Table 1

Risk of Bias according to the APTA CAT-EI Tool

Author, year, quality levelI CECRecruitment minimize biasA priori power analysisRandomly assigned to interventionTreatment group concealedCGSubjects blinded to treatment groupIntervention reproducibleAdherence describedAdverse effectsConflict of interest

Bozdemir

2021,

II Acceptable

YYYYYYYYYNNY

Omidi,

2020,

II Acceptable

YYYYYYYNNYNY

Bland,

2019,

II Acceptable

YYYNYNYNYNNY

Simoncini

2017,

II Acceptable

YYYYYNYNYYYY

Cansiz, 2022,

III Low

YYNAYNANANNAYYNY

Paskett,

2021,

III Low

YYYYYNNNYYNY

Liu,

2021,

III Low

YYNNNNNNYYNY

Naughton

2021,

III Low

YYYNYNYNYYNY

Koelmeyer,

2020,

III Low

YYYNNNNNYYNY

Ridner,

2020,

III Low

YYYNYNYNYYNY

Zhang,

2020,

III Low

YYNNYNYNNNNY

Arinaga,

2016,

III Low

YYNYNNNNYYYND

Lu,

2015,

III Low

YYNNNNYNYNNY

Singh, 2013,

III Low

YYNNNNYYYNNY

Cho,

2012,

III Low

YYYYYNYNYNNY

IC inclusion criteria, EC exclusion criteria, Y yes present, N no absent, CG Control Group, ND not declared, NA not applicable

Risk of Bias according to the APTA CAT-EI Tool Bozdemir 2021, II Acceptable Omidi, 2020, II Acceptable Bland, 2019, II Acceptable Simoncini 2017, II Acceptable Cansiz, 2022, III Low Paskett, 2021, III Low Liu, 2021, III Low Naughton 2021, III Low Koelmeyer, 2020, III Low Ridner, 2020, III Low Zhang, 2020, III Low Arinaga, 2016, III Low Lu, 2015, III Low Singh, 2013, III Low Cho, 2012, III Low IC inclusion criteria, EC exclusion criteria, Y yes present, N no absent, CG Control Group, ND not declared, NA not applicable

Results

The search identified 968 studies and 45 underwent full-text review. Seventeen studies published between January 2011 and December 2021 met the study inclusion criteria and were included in the review. The review did not yield any high-quality studies, and 2 were deemed unacceptable. As a result, 15 studies of acceptable and low quality were included (4 acceptable and 11 low quality). Five of the studies were conducted in the USA, 2 studies each were conducted in China and Turkey, and 1 study from each of the following countries: Australia, Canada, Italy, Iran, Japan, and Taiwan. There were 9 randomized controlled trials, 1 retrospective, and 5 prospective pre/post study designs.

Study characteristics

Demographic characteristics

Participants across all studies (combined N = 2230) were women diagnosed with BC with or without lymphedema that received education. Participant demographics varied and included at least some or all of the following characteristics: mean age of 53.9 years (range 47.43–61.0), mean body mass index of 25.75 (range 23.91–35.0), stages of BC ranged from I to III, axillary lymph node dissection, sentinel node biopsy, radiation therapy, and chemotherapy [9, 17–30]. Ten of the studies examined education for those at risk of developing BCRL, and 5 studies included women previously diagnosed with BCRL, stage I, II, or III. These participants presented with a wide range of mean duration of lymphedema from 6.86 months (SD 3.7) [20, 29] to > 5 years [27, 30].

BCRL education

Timing of BCRL education occurred at multiple time points across the trajectory of BC care. The pre-operative phase of BC care included one-on-one in person education with a healthcare professional [17, 21–24]. During this encounter, printed educational materials regarding post-operative BC care and BCRL risk reduction and protective measures were provided. Timing allotted for this educational session varied and either lasted up to 40 min [24] or was not reported [17, 23]. Follow up educational content was repeated either post-operatively [24] or at 6 months [17, 23]. In the studies reviewed, although education was a primary aim, only one investigated knowledge assessment and its acquisition [24]. Additionally, outcome measures varied and focused on function, quality of life, arm volume, BCRL incidence rates, and adherence to self-care. The education provided also varied in timing, mode, content, and frequency across the trajectory of care. The details are provided in Table 2.
Table 2

Summary of breast cancer-related lymphedema educational content, mode, and timing

Author, year, (quality rating) timing study designCharacteristics of participant in the intervention groupMode of BCRL education delivery for intervention groupEducational content for intervention groupAdditional rehabilitation treatments for the intervention group (PT or lymphedema specialist)Educational content for control groupMode of delivery for control groupKnowledge/learning assessment

Bland, 2019, (A)

Pre-operative

RCT

n = 64

BC stage: 0, I, II, III, IV

Surgery:

Mastectomy + axillary surgery

Lumpectomy + axillary surgery

Lumpectomy

Mean age: 52.64 years

One on one Booklet, Lecture, discussion, Patient education manual

Training repeated at 1 time point (6 months)

Education on protective measures: injury, infection, overheating, overexertion, constrictionNone reportedStandard pre-op BC surgical counseling: discussion with surgeon, risk, and complications of surgery, “mentioned BCRL with some protective care”One on one discussion, BookletNo knowledge assessment following education reported

Bozdemir, 2021, (A)

Post- operative

RCT

n = 29

BC stage: II and III

Surgery:

MRM

BC protection surgery + ALND or BC protection surgery + SLND

Overall mean age: 48.9 ± 9 years

Post-op with a nurse

Telephone consultancy

Training booklet with link to WhatsApp

Education repeated at 2 time points

Definition of lymphedema, signs and symptoms, risk factors, prevention, exercises, and self-lymph massageNone reportedStandard nursing care questions answered as neededNot reportedNo knowledge assessment following education reported

Simoncini, 2017, (A)

Post- operative

RCT

N = 84

BC tumor size: 0, 1, 2, 3, X Surgery: Total mastectomy + ALND

Nipple sparing mastectomy + ALND

Quadrantectomy + ALND

ALND

Mean age: 50.6 10.9) years

Post-op group ED guided by PT

Group rehab supported by visual information—1 session 3–4 people discussion supported by images. Interactive methods and cognitive behavioral strategies

One session, no further training

Lymphatic system; definition of lymphostasis, lymphangitis, lymphedema, and axillary web syndrome; when and how to do exercises, joint range, and muscle

Strengthening, QoL advice

GRV: 20.2% needed additional information and 39.2% needed physiotherapy for axillary web syndrome, edema or difficulty with shoulder ROM

Lymphatic system; definition of lymphostasis, lymphangitis, lymphedema, and axillary web syndrome; when and how to do exercises, joint range, and muscle

Strengthening, QoL advice

UR: one on one education session with PT X 1 session

23.2% needed additional information and 46.3% needed physiotherapy

No knowledge assessment following education reported
Omidi, 2020, (A) Diagnosed with BCRL

Group n = 32

Social Network n = 34

BC stage: I, II, III, IV

Surgery:

MRM

BCS

BCRL stage: I, II, III diagnosis established by a MD

Age:

Group; 52.47 (10.62)

Social network 50.44 (8.81)

BMI:

Group 28.04 (5.07)

Social network

28.41 (5.10)

Duration of LE (months):

Group 6.22 (3.86)

Social network

7.50 (3.510

Group-based ED

ED material presented in 5 sessions 60 to 90 min each 2 × weekly with 4 sessions of LE self-management and one session stress-management

Social network ED

Telegram messenger where ED upload 2 × week for 3 weeks. 20 audio and photo messages provided. Confirmation of information received

ED same for both groups and included: lymphedema self- management education and stress management strategies; problem solving and decision-making, using resources, applying personalized cares, cooperating with treatment team, and sharing skills with caregiversAll participants received routine BCRL treatment by a lymphedema specialist; 20 sessions of CDT, brochure on care/prevention of BCRL and CD for rehabilitation exercisesIncluded: lymphedema self-management education and stress management strategies; problem solving and decision-making, using resources, applying personalized cares, cooperating with treatment team, and sharing skills with caregiversCD of educational content at end of study

No knowledge assessment following education

reported

Singh, 2013, (L)

Pre-operative

Prospective quazi-experimental

n = 41

BC stage: DCIS, I, II, III, unknown

Surgery:

MRM

BCS

Age: 55.1 (14.8) years

BMI: kg/m2 27.1 (5.4)

Same as control group

One on one with PT and printed educational materials

Monitoring visits at 1 and 6 months

Standard post op care: post op exercise for mobility including AROM and AAROM; activity modification scar massage and prevention of BCRL

General information (definition of lymphedema, time course of development, early signs, and symptoms), risk reduction behaviors; modifiable and non-modifiable risk factors

Same as control group + 

further BCRL self -management strategies: lymphedema management, compression bandaging/garment, progression of shoulder exercises and scar massage as needed

Individualized

PT as needed

Standard post op care: post op exercise for mobility including AROM and AAROM; activity modification scar massage and prevention of BCRL

General information (definition of lymphedema, time course of development, early signs, and symptoms), risk reduction behaviors; modifiable and non-modifiable risk factors

One on one with PT and printed educational materialsNo knowledge assessment following education reported

Cho, 2012, (L)

Pre-operative

Post- operative

RCT

Papilla gown n = 30

Papilla gown + ED

n = 28

Ed = 58

BC stage: II and III with ALND

Surgery: total mastectomy or

MRM with drain

Overall mean age: 55.2 (12.6)

Pre-op one on one ED sessions with nurse for 40 min

Post-op ED session with nursing reinforcing lymphedema prevention

No further training

Pre-op: reach to recovery exercises; pictorial handbook of post -surgical BC care and BCRL management

Post-op: Understanding and Prevention of BCRL, arm swelling and shoulder immobility

None reported

Standard care:

standard hospital gown + post-op surgical instruction; but not described

One on one by nurse or surgeon

Investigator-designed BC knowledge questionnaire

Significant higher knowledge scores for those who had education 0.36 (95% CI 0.30 − 0.40) compared to no education 0.11 (95% CI 0.07–0.15)

p = 0.0001

Paskett, 2021, (L)

Pre-operative

RCT

Lymphedema education and prevention

n = 68

Surgery:

Partial mastectomy/lumpectomy/biopsy

Mastectomy

SLND/ALND

Age: 58 (27–88)

One on one ED with lymphedema expert

Follow up at 12 and 18 months post-surgery

Adherence reminder telephone call at 9 and 15 months

ACS guidelines

Lymphedema etiology, signs and symptoms, treatments, and preventative self-care practices

Garment use during exercise (study or personal), air travel and/ or vigorous activity. Juzo class I 20–30 mmHg

PT assessment and instruction on individualized 15 min exercise regime involving breathing, stretching, strengthening (2# hand weight) and personalized ROM exercises. Home video

One on one Ed with lymphedema expert

Address verification telephone call at 9 and 15 months

ACS guidelines

for lymphedema care/ prevention Lymphedema etiology, signs and symptoms, treatments, and preventative self-care practices

No knowledge assessment following education reported

Naughton, 2020, (L)

Pre-operative

RCT, secondary analysis of Paskett, 2021

Lymphedema education and prevention

n = 68

Surgery:

Partial mastectomy/lumpectomy/ biopsy

Mastectomy

SLND/ALND

Age: 58 (27–88)

One on one ED with lymphedema expert

Follow up at 12 and 18 months post-surgery

Adherence reminder telephone call at 9 and 15 months

ACS guidelines

Lymphedema etiology, signs and symptoms, treatments, and preventative self-care practices

Garment use during exercise (study or personal), air travel and/ or vigorous activity. Juzo class I 20–30 mmHg

PT assessment and instruction on individualized 15 min exercise regime involving breathing, stretching, strengthening (2# hand weight) and personalized ROM exercises. Home video

One on one Ed with lymphedema expert

Address verification telephone call at 9 and 15 months

ACS guidelines

for lymphedema care/prevention lymphedema etiology, signs and symptoms, treatments, and preventative self-care practices

No knowledge assessment following education reported

Lu, 2015, (L)

Post- operative

Cohort study

ED n = 672

ED + PT n = 130

BC stage: I, II, III

Surgery:

BCS

Simple mastectomy

MRM

ALND

Age:

ED 52.67 ± 11.01

Ed + PT 51.88 ± 10.08

BMI:

Ed 24.24 ± 3.75

Ed + PT 23.91 ± 3.65

ED with PT, ED alone

published guidelines from NLN; patient-centered ED program if requested with specialized PT printed material

One visit, no further training

lymphatic system, signs of BCRL, prevention strategies, postop ex, modifying ex, scar massage, maintain healthy body weight, avoid trauma or infection, venipuncture of limbPT provided Breathing ex, post-surgical positioning, scar massage, soft tissue stretching, shoulder mobilizations and exercisesNo education and no physical therapyN/ANo knowledge assessment following education reported

Zhang, 2020, (L)

Post-operative

RCT

n = 43

BC stage: I and II

BCRL stage: I, II and III

Age: 47.43 ± 6.81

BMI: 24.8

Problem-based learning with nurse facilitators, One on one and groups sessions (3–5 women per group); use of books, internet, health ED, posters, brochures; WeChat group

Twice per week for 30 min during hospital admission. Once per week for 30 min following discharge

Unknown for weeks duration

Patient self-care, proper ex, use of compression sleeve and body massage; other BC issues as proposed by patients during group discussionsNone reportedBasic health guidance on post-op diet, early functional rehabilitation, chemotherapy, radiation, PICC and PORT catheter maintenance30 min lecture 2 × week prior to d/c; s/p discharge health ED content via WeChat weekly for self-managementNo knowledge assessment following education reported

Koelmeyer, 2020, (L)

Post-operative

Prospective single group intervention

n = 20

Node positive invasive BC

Surgery: mastectomy

ALND or SLND

High risk for BCRL

Age: 54 (12)

BMI: 26 (5)

Package provided

Prospective surveillance model of care that consisted of BIS monitoring, education, and support to promote self-management and physical activity

Education—risk minimization and provision of the Australian Cancer Council Understanding Lymphoedema fact sheet. Self-management strategies included skin care, exercise, self-lymphatic drainage massage, compression, and use of pneumatic compression

6 months follow up

If participants had increased LDex score about normal, or observable signs of BCRL, referred to “Lymphedema therapist” for standard clinical care (not defined)NANA

No knowledge assessment following education

reported

Ridner, 2020, (L) Diagnosed with BCRL

RCT

n = 47

Surgery:

BCS

Mastectomy

BCRL stage: 2 diagnosis as per International society of lymphedema

Age: 59.8 (8.6)

Web-based multimedia with Videos

12 videos each 20–45 min; long narrative, reflective questions and interviews from patients sharing stories of living with

BCRL. To be completed within 1 month

BCRL self-care: Physiology of lymphatic system, self-care tasks, goal setting, rewards, diet and exercises, methods of dealing with negative emotions and stress, body images changes, uncertainty and enhancing emotional and instrumental social support. Looking at life from a different perspective and a new identityN/A

BCRL risk reduction, early warning signs, Rx advice, emotions and LE and cost of Rx

To be completed within 1 month

Educational PamphletNo knowledge assessment following education reported

Arinaga 2016 (L)

Diagnosed with BCRL

Prospective longitudinal single group pre-post intervention

n = 23

Surgery:

BCS

Mastectomy

ALND

SLND

BCRL stage: I + II per common terminology

Months since onset of BCRL: 17.00 (1 to 132)

criteria for adverse events

Age: median 61 (29–71) years

BMI: 23.1 (19.3–31.1)

One meeting to teach Self-care program to be completed for 10 min daily

Phone call follow up at 1 week, 2, 4, 5 months

Self-care including basic self-care education not explained, Japanese radio calisthenics, skin moisturizing with grapefruit oil and sweet almond massage oil, self-lymphatic drainageN/AN/AN/ANo knowledge assessment following education reported

Cansiz 2022 (L)

Diagnosed with BCRL

Prospective

Quazi-experimental

n = 44

BC stage: I, II + III

Surgery:

MRM 72.7%

BCRL stage: slight, moderate, and Marked according to the Stillwell classification

Age: 52.6 ± 8.3

BMI:

20–25 31.8%

25–30 45.5%

30–35 22.7%

Face to face education program with a nurse

Oral presentation with visual content supported by a PowerPoint

Question and answers

Booklet

40 min

12-month follow up by phone

Self-management lymphedema

Definition of BCRL

Its causes, skin care, conditions to be considered, compression therapy, self-manual lymphatic drainage, movements to avoid, benefits and aims and types of exercise

Exercise and self-manual lymphatic drainage 3 days per week 2 times per day for 12 months

To wear compression while exercising and during day

N/AN/AN/ANo knowledge assessment following education reported

Liu, 2021 (L)

Diagnosed with BCRL

Longitudinal quasi-experimental

n = 41

BC stage: I, II + III

Surgery:

BCS

Partial mastectomy

Total mastectomy

MRM

BCRL stage: Subclinical or mild stage due to a limb circumference difference of 1–3 cm

Age: 58.0 ± 12.48

BMI: 25.17 ± 3.25

Face to face individual education session

Handbook

demonstration and feedback of exercises

30 min

Follow up 4 face to face review sessions at 1, 3, 6, and 12 months

15 telephone contacts—one per week first month then 1 per month for 11 months

Optimal lymph flow program daily self-management strategies including basic knowledge about BCRL, exercises to promote lymph flow and drainage, arm precautions to improve limb functional status, instructions to optimize BMIN/AN/AN/ANo knowledge assessment following education reported

A acceptable quality, L low quality, QoL quality of life, BC breast cancer, BCRL breast cancer–related lymphedema, BMI body mass index, PT physical therapist, ED education, CDT complete decongestive therapy, Ex exercises, NLN National Lymphedema Network, N/A not applicable, BCS breast conserving surgery, MRM modified radical mastectomy, ALND axillary lymph node dissection, SLND sentinel lymph node dissection, LN lymph node, LE lymphedema, RCT randomized controlled trial, SD standard deviation, ISL International Society of Lymphology

Summary of breast cancer-related lymphedema educational content, mode, and timing Bland, 2019, (A) Pre-operative RCT n = 64 BC stage: 0, I, II, III, IV Surgery: Mastectomy + axillary surgery Lumpectomy + axillary surgery Lumpectomy Mean age: 52.64 years One on one Booklet, Lecture, discussion, Patient education manual Training repeated at 1 time point (6 months) Bozdemir, 2021, (A) Post- operative RCT n = 29 BC stage: II and III Surgery: MRM BC protection surgery + ALND or BC protection surgery + SLND Overall mean age: 48.9 ± 9 years Post-op with a nurse Telephone consultancy Training booklet with link to WhatsApp Education repeated at 2 time points Simoncini, 2017, (A) Post- operative RCT N = 84 BC tumor size: 0, 1, 2, 3, X Surgery: Total mastectomy + ALND Nipple sparing mastectomy + ALND Quadrantectomy + ALND ALND Mean age: 50.6 10.9) years Post-op group ED guided by PT Group rehab supported by visual information—1 session 3–4 people discussion supported by images. Interactive methods and cognitive behavioral strategies One session, no further training Lymphatic system; definition of lymphostasis, lymphangitis, lymphedema, and axillary web syndrome; when and how to do exercises, joint range, and muscle Strengthening, QoL advice Lymphatic system; definition of lymphostasis, lymphangitis, lymphedema, and axillary web syndrome; when and how to do exercises, joint range, and muscle Strengthening, QoL advice UR: one on one education session with PT X 1 session 23.2% needed additional information and 46.3% needed physiotherapy Group n = 32 Social Network n = 34 BC stage: I, II, III, IV Surgery: MRM BCS BCRL stage: I, II, III diagnosis established by a MD Age: Group; 52.47 (10.62) Social network 50.44 (8.81) BMI: Group 28.04 (5.07) Social network 28.41 (5.10) Duration of LE (months): Group 6.22 (3.86) Social network 7.50 (3.510 Group-based ED ED material presented in 5 sessions 60 to 90 min each 2 × weekly with 4 sessions of LE self-management and one session stress-management Social network ED Telegram messenger where ED upload 2 × week for 3 weeks. 20 audio and photo messages provided. Confirmation of information received No knowledge assessment following education reported Singh, 2013, (L) Pre-operative Prospective quazi-experimental n = 41 BC stage: DCIS, I, II, III, unknown Surgery: MRM BCS Age: 55.1 (14.8) years BMI: kg/m2 27.1 (5.4) Same as control group One on one with PT and printed educational materials Monitoring visits at 1 and 6 months Standard post op care: post op exercise for mobility including AROM and AAROM; activity modification scar massage and prevention of BCRL General information (definition of lymphedema, time course of development, early signs, and symptoms), risk reduction behaviors; modifiable and non-modifiable risk factors Same as control group + further BCRL self -management strategies: lymphedema management, compression bandaging/garment, progression of shoulder exercises and scar massage as needed Individualized PT as needed Standard post op care: post op exercise for mobility including AROM and AAROM; activity modification scar massage and prevention of BCRL General information (definition of lymphedema, time course of development, early signs, and symptoms), risk reduction behaviors; modifiable and non-modifiable risk factors Cho, 2012, (L) Pre-operative Post- operative RCT Papilla gown n = 30 Papilla gown + ED n = 28 Ed = 58 BC stage: II and III with ALND Surgery: total mastectomy or MRM with drain Overall mean age: 55.2 (12.6) Pre-op one on one ED sessions with nurse for 40 min Post-op ED session with nursing reinforcing lymphedema prevention No further training Pre-op: reach to recovery exercises; pictorial handbook of post -surgical BC care and BCRL management Post-op: Understanding and Prevention of BCRL, arm swelling and shoulder immobility Standard care: standard hospital gown + post-op surgical instruction; but not described Investigator-designed BC knowledge questionnaire Significant higher knowledge scores for those who had education 0.36 (95% CI 0.30 − 0.40) compared to no education 0.11 (95% CI 0.07–0.15) p = 0.0001 Paskett, 2021, (L) Pre-operative RCT Lymphedema education and prevention n = 68 Surgery: Partial mastectomy/lumpectomy/biopsy Mastectomy SLND/ALND Age: 58 (27–88) One on one ED with lymphedema expert Follow up at 12 and 18 months post-surgery Adherence reminder telephone call at 9 and 15 months ACS guidelines Lymphedema etiology, signs and symptoms, treatments, and preventative self-care practices Garment use during exercise (study or personal), air travel and/ or vigorous activity. Juzo class I 20–30 mmHg One on one Ed with lymphedema expert Address verification telephone call at 9 and 15 months ACS guidelines for lymphedema care/ prevention Lymphedema etiology, signs and symptoms, treatments, and preventative self-care practices Naughton, 2020, (L) Pre-operative RCT, secondary analysis of Paskett, 2021 Lymphedema education and prevention n = 68 Surgery: Partial mastectomy/lumpectomy/ biopsy Mastectomy SLND/ALND Age: 58 (27–88) One on one ED with lymphedema expert Follow up at 12 and 18 months post-surgery Adherence reminder telephone call at 9 and 15 months ACS guidelines Lymphedema etiology, signs and symptoms, treatments, and preventative self-care practices Garment use during exercise (study or personal), air travel and/ or vigorous activity. Juzo class I 20–30 mmHg One on one Ed with lymphedema expert Address verification telephone call at 9 and 15 months ACS guidelines for lymphedema care/prevention lymphedema etiology, signs and symptoms, treatments, and preventative self-care practices Lu, 2015, (L) Post- operative Cohort study ED n = 672 ED + PT n = 130 BC stage: I, II, III Surgery: BCS Simple mastectomy MRM ALND Age: ED 52.67 ± 11.01 Ed + PT 51.88 ± 10.08 BMI: Ed 24.24 ± 3.75 Ed + PT 23.91 ± 3.65 ED with PT, ED alone published guidelines from NLN; patient-centered ED program if requested with specialized PT printed material One visit, no further training Zhang, 2020, (L) Post-operative RCT n = 43 BC stage: I and II BCRL stage: I, II and III Age: 47.43 ± 6.81 BMI: 24.8 Problem-based learning with nurse facilitators, One on one and groups sessions (3–5 women per group); use of books, internet, health ED, posters, brochures; WeChat group Twice per week for 30 min during hospital admission. Once per week for 30 min following discharge Unknown for weeks duration Koelmeyer, 2020, (L) Post-operative Prospective single group intervention n = 20 Node positive invasive BC Surgery: mastectomy ALND or SLND High risk for BCRL Age: 54 (12) BMI: 26 (5) Prospective surveillance model of care that consisted of BIS monitoring, education, and support to promote self-management and physical activity Education—risk minimization and provision of the Australian Cancer Council Understanding Lymphoedema fact sheet. Self-management strategies included skin care, exercise, self-lymphatic drainage massage, compression, and use of pneumatic compression 6 months follow up No knowledge assessment following education reported Ridner, 2020, (L) Diagnosed with BCRL RCT n = 47 Surgery: BCS Mastectomy BCRL stage: 2 diagnosis as per International society of lymphedema Age: 59.8 (8.6) Web-based multimedia with Videos 12 videos each 20–45 min; long narrative, reflective questions and interviews from patients sharing stories of living with BCRL. To be completed within 1 month BCRL risk reduction, early warning signs, Rx advice, emotions and LE and cost of Rx To be completed within 1 month Arinaga 2016 (L) Diagnosed with BCRL Prospective longitudinal single group pre-post intervention n = 23 Surgery: BCS Mastectomy ALND SLND BCRL stage: I + II per common terminology Months since onset of BCRL: 17.00 (1 to 132) criteria for adverse events Age: median 61 (29–71) years BMI: 23.1 (19.3–31.1) One meeting to teach Self-care program to be completed for 10 min daily Phone call follow up at 1 week, 2, 4, 5 months Cansiz 2022 (L) Diagnosed with BCRL Prospective Quazi-experimental n = 44 BC stage: I, II + III Surgery: MRM 72.7% BCRL stage: slight, moderate, and Marked according to the Stillwell classification Age: 52.6 ± 8.3 BMI: 20–25 31.8% 25–30 45.5% 30–35 22.7% Face to face education program with a nurse Oral presentation with visual content supported by a PowerPoint Question and answers Booklet 40 min 12-month follow up by phone Self-management lymphedema Definition of BCRL Its causes, skin care, conditions to be considered, compression therapy, self-manual lymphatic drainage, movements to avoid, benefits and aims and types of exercise Exercise and self-manual lymphatic drainage 3 days per week 2 times per day for 12 months To wear compression while exercising and during day Liu, 2021 (L) Diagnosed with BCRL Longitudinal quasi-experimental n = 41 BC stage: I, II + III Surgery: BCS Partial mastectomy Total mastectomy MRM BCRL stage: Subclinical or mild stage due to a limb circumference difference of 1–3 cm Age: 58.0 ± 12.48 BMI: 25.17 ± 3.25 Face to face individual education session Handbook demonstration and feedback of exercises 30 min Follow up 4 face to face review sessions at 1, 3, 6, and 12 months 15 telephone contacts—one per week first month then 1 per month for 11 months A acceptable quality, L low quality, QoL quality of life, BC breast cancer, BCRL breast cancer–related lymphedema, BMI body mass index, PT physical therapist, ED education, CDT complete decongestive therapy, Ex exercises, NLN National Lymphedema Network, N/A not applicable, BCS breast conserving surgery, MRM modified radical mastectomy, ALND axillary lymph node dissection, SLND sentinel lymph node dissection, LN lymph node, LE lymphedema, RCT randomized controlled trial, SD standard deviation, ISL International Society of Lymphology The post-operative phase of BC care utilized 3 different modes of education, which included one-on-one [19], small groups (3–4 participants) [18, 20], or social media (WeChat) [26]. During the one-on-one session, printed material with an accompanying visual presentation was conducted. BCRL content included risk reduction practices, shoulder range of motion, self-management, and physical activity. The group sessions offered similar content with the additional inclusion of BCRL behavioral strategies [20]. Education delivered via social media focused on participants’ discussion of self-identified problems followed by group-guided solutions. A healthcare professional then summarized the solutions identified by the participants [26]. Only one study provided follow up education via WhatsApp at 1 and 3 months post-operatively [19]. Unfortunately, the studies did not delineate between the confounding variables, the outcome of the education intervention, and the development of BCRL. For individuals who developed BCRL, education was provided in a variety of modes including one-on-one sessions, [27, 28, 30], small group (3–5 participants) [20], social media (Telemessenger) [20], and web-based video presentation [29]. The education used printed materials, visual aids, group discussion, demonstration, and feedback as learning modes [20, 27–30]. The BCRL education emphasized self-care and self-management, therapeutic exercises, self-manual lymph drainage, and utilization of a compression garment [20, 27–30]. Timing of each session ranged from 30 to 90 min over 4 to 5 sessions. The 12 web-based videos took 20–45 min to review [29]. Ridner et al. found the shorter the educational time expectation, the higher the completion of the program [29]. Follow up education varied in frequency from weekly, monthly, to 1 year. Mode of follow up education was either by telephone or in person [27, 28, 30].

Outcome measures

The 4 acceptable studies included one or more of the following outcome measures: arm volume via calculated formula or arm circumference, quality of life via the Functional Assessment of Cancer Therapy-Breast (FACT-B) or the Lymphedema Life Impact Scale (LLIS), and functional outcomes via the Disabilities of the Arm, Shoulder, and Hand (DASH), LLIS, or the Subject Perception of Post-operative Functional Impairment of the Arm (SPOFIA) (Table 3). Although Bozdemir 2021 demonstrated significant reduction with arm circumference, volume was not calculated [19]. Clinically, arm circumference by itself is not considered a valid and reliable diagnostic method to detect BCRL in those at risk [31]. In 2 studies, improvement in quality of life was statistically significant as measured by the FACT-B (p = 0.048 at 6 months) and by the LLIS (p = 0.007 at 3 months) [17, 20]. Additionally, functional improvement was statistically significant at 3 months follow up in 2 of the acceptable studies as measured by the DASH (p ≤ 0.05), SPOFIA (p ≤ 0.05) [19], and the LLIS (p = 0.024) [20]. One complication following treatment for BC is post-operative wound infection, which may be a contributing factor to the development of lymphedema [32]. Only one study reported the incidence of postoperative surgical wound infection and adherence to the BCRL education. Infection was insignificant (p = 0.26), and adherence rates (65%) were similar in both the intervention and control groups [18]. Notably, those participants who received BCRL education and requested follow-up sessions with a physical therapist were fully adherent to the post-operative education provided. BCRL education was not examined as an individual intervention in all studies except one; rather, it was a component of the overall plan of care. Therefore, the effect of education on these outcome measures was not specifically examined. In order to determine the impact of BCRL education, knowledge acquisition as an outcome measure pre- and post-education needs to be assessed. Zhang (2020), a low-quality study, attempted to indirectly assess knowledge acquisition in patients with and those at risk for BCRL using the Exercise of Self Care Agency Scale (ESCA) [26]. This scale included 4 domains, one of which investigated level of health knowledge. The problem-based learning intervention group was instructed to perform self-massage, ROM, and utilization of a compression sleeve. Although the ESCA scores demonstrated significant improvement (p < 0.05) at discharge, 1 month, and 3 months post discharge, learning was not directly assessed. This result infers that adherence to self-care practices reflects knowledge acquisition.
Table 3

Outcome measures and results

Author, year, timing of education, sample size (N =)Arm volumeQuality of lifeFunctionComplicationsAdherenceOther outcomes
Acceptable

Bland, 2019,

Pre-operative Education; at post-op visit Breast surgery rehab class; @ 6 months refresher with LE expert (N = 119, intervention n = 64)

Measured but results not presented

FACT-B

6 months

p = 0.048*

Not an outcomeNot an outcomeNot an outcome

Incidence of BCRL

Intervention group: 33 within 1 yr (52%);

6 > 1 yr (9%)

Control group: 26 within 1 yr (47%)

7 after 1 yr (13%)

Intervention group: greater number of SNB (p = 0.002) and ALND

Simoncini, 2017,

Post-operative education (N = 161, Intervention n = 79)

Circumferential Calculated arm volume formula

Change 0.7 (5.3)

p = 0.69

FACT-B

p = 0.65

DASH

p = 0.81

Surgical wound infections 12.7%

p = 0.26

65.5% p = 0.92N/A

Bozdemir, 2021,

Post-operative education (N = 58, Intervention n = 29)

Arm circumference

Right arm circumference > left p < 0.05* significant

Not an outcome

DASH

p < 0.05*

SPOFIA p < 0.05*

Not an outcomeNot an outcomeN/A

Omidi, 2020,

Education for women with BCRL (N = 105, Intervention groups n = 35 each)

Not applicable

Persian version of the LLIS

(group education)

3/12 significant improved QoL over time

p = 0.007*

Part of Persian version LLIS (group education)

Reduced impairment

Significant over time

p = 0.024*

Not an outcomeNot an outcomeN/A
Low

Paskett, 2021,

Pre-operative

education (N = 554, Intervention n = 312)

Arm circumference

No difference 12/12 − 0.04; 95% CI, − 0.97 to 0.88;

p = 0.93

18/12 0.34; 95%CI − 0.97 to 1.64; p = 0.61

Not an outcomeNot an outcomeNot an outcome

Sleeve/gauntlet use and exercises50% performed breathing/lymph flow, stretching, and strengthening ex as instructed

31% wore elastic garments as prescribed

No association with sleeve use at 6/12 and lymphedema rates (OR 0.74; 95% CI, 0.40 to 1.36; p = 0.33

N/A

Naughton, 2021,

Pre-operative education (N = 547, Intervention n = 309)

Limb volume

No difference in preventing LE

p = 0.37

FACT-B + 4

p = 0.88 at 18 months not significant

African American patients had better emotional functioning

p = 0.0335*

Not an outcomeNot an outcomeAdherence to the LEAP exercises 50% and 31% wore the compression garment as prescribed due to lack of time and perceived benefitN/A

Singh, 2013,

Pre-operative education (N = 72, Intervention n = 41)

Not an outcome

FACT-B

105.42 (18.3)

Change 1.92 (16.21)

p = 0.43

DASH

18.3 (18.7)

Change 4.76 (16.65)

p = 0.27

Not an outcomeNot an outcomeN/A

Cho, 2012,

Pre-and post-operative education (N = 145, Intervention n = 58)

Arm Circumference

p = 0.0097*

Not an outcome

Postmastectomy Activity Scale

p ≤ 0.0001*

4.34 (95% CI 4.21–4.49 T1

T2 − 5.12 (95%CI: 4.91–5.34)

Not an outcome

Adherence to wearing the gown and increased exercise

p = 0.039*

N/A

Koelmeyer, 2020,

Post-operative education (N = 20, Intervention n = 20)

L-Dex

(> + 6.5 defines as lymphedema)

25% had an increase of >  + 6.5 in 3 months

Lymphedema Symptom, Intensity and Distress Survey Arm version

Decreased by 0.4 out of 10.0 (95%CI 0.1 to 0.7) over 6 months

p < 0.05*

Incidental and planned Exercise Questionnaire

No increase in total

Physical activity but there was an increase of 2.8 h per week (95% CI 0.4 to 5.2)

p < 0.05* of planned exercise over 6 months

Not an outcomeAdherence to measuring 3 times per week 74% (SD 24; range 33 to 11) during 3 monthsN/A

Zhang, 2020,

Post-operative education (N = 85, Intervention n = 43)

Circumferential

Chinese version FACT-B

Significant at 3 months

p < 0.05 *

Not an outcomeNot an outcomeNot an outcomeN/A

Lu, 2015,

Post-operative education (N = 1217, Intervention n = 672)

Circumferential > 2 cm differenceNot an outcomeNot an outcomeNot an outcomeNot an outcomeN/A

Cansiz, 2021,

Education for women with BCRL (N = 44, intervention n = 44)

Limb volume calculated

(p = 0.000)*

Bioimpedance L-Dex no final data due to Covid-19

Adaptation to Chronic Illness Scale

(p = 0.001)*

Patient Activation Measure

(p = 0.000)*

Katz Index of Independence in Active Daily Living Scale

(p = 0.018)*

DASH

(p = 0.000)*

Not an outcomeNot an outcomeN/A

Liu, 2021,

Education for women with BCRL (N = 41, intervention n = 40)

Limb circumference

Significant lower at 4 months follow up

p = 0.006*

Not an outcomeNot an outcomeNot an outcomeNot an outcome

Breast cancer and lymphedema Symptom experience index

Significant changes in functional, social, emotional, and psychological and self-perception among 5 test points (p ≤ 0.05)*

No difference in sleep and sexuality

(p > 0.05)

Ridner, 2020,

Education for women with BCRL

(N = 109, Intervention n = 47)

Bioimpedance

No significant difference

Cohen’s d =  + 0.36

LSIDS-A

no significant difference in reduction of symptoms effect size = 0.05–0.28; p > 0.05*

Quick DASH

No statistical difference

p > 0.05

Effect size pamphlet group − 0.19 greater increase in function/wellbeing

than web-based group + 0.30

Not an outcome

Pamphlet group 62 (77.5%) completed their program

Web-based multimedia

47 (58.8% completed their program

p = 0.011

Web based took longer to do

N/A

Aringa, 2016,

Education for women with BCRL (N = 23)

Limb volume

(p = 0.01)*

Tonometer

LYMQOL

Discomfort

(p = 0.00)*

Sensory alternation

(p = 0.02)*

Swelling

(p = 0.02)*

Heaviness

(p = 0.05)*

ULL-27

No significant change

Not an outcome

Perceived adherence for self-care

(p = 0.01)*

Self-rated skin condition

No significant difference

DASH Disability of Arm, Shoulder, and Hand questionnaire, SPOFIA Subject Perception of Post-Operative Functional Impairment of the Arm, LLIS Lymphedema Life impact Scale, FACT B + 4 Functional Assessment of Cancer Therapy Breast + Arm Morbidity Subscale, LSIDS-A Lymphedema Symptom and Distress Scale- Arm, BCRL breast cancer–related lymphedema, yr year, OR odds ratio, CI confidence interval, LE lymphedema

*Significant

Outcome measures and results Bland, 2019, Pre-operative Education; at post-op visit Breast surgery rehab class; @ 6 months refresher with LE expert (N = 119, intervention n = 64) FACT-B 6 months p = 0.048* Incidence of BCRL Intervention group: 33 within 1 yr (52%); 6 > 1 yr (9%) Control group: 26 within 1 yr (47%) 7 after 1 yr (13%) Intervention group: greater number of SNB (p = 0.002) and ALND Simoncini, 2017, Post-operative education (N = 161, Intervention n = 79) Circumferential Calculated arm volume formula Change 0.7 (5.3) p = 0.69 FACT-B p = 0.65 DASH p = 0.81 Surgical wound infections 12.7% p = 0.26 Bozdemir, 2021, Post-operative education (N = 58, Intervention n = 29) Arm circumference Right arm circumference > left p < 0.05* significant DASH p < 0.05* SPOFIA p < 0.05* Omidi, 2020, Education for women with BCRL (N = 105, Intervention groups n = 35 each) Persian version of the LLIS (group education) 3/12 significant improved QoL over time p = 0.007* Part of Persian version LLIS (group education) Reduced impairment Significant over time p = 0.024* Paskett, 2021, Pre-operative education (N = 554, Intervention n = 312) Arm circumference No difference 12/12 − 0.04; 95% CI, − 0.97 to 0.88; p = 0.93 18/12 0.34; 95%CI − 0.97 to 1.64; p = 0.61 Sleeve/gauntlet use and exercises50% performed breathing/lymph flow, stretching, and strengthening ex as instructed 31% wore elastic garments as prescribed No association with sleeve use at 6/12 and lymphedema rates (OR 0.74; 95% CI, 0.40 to 1.36; p = 0.33 Naughton, 2021, Pre-operative education (N = 547, Intervention n = 309) Limb volume No difference in preventing LE p = 0.37 FACT-B + 4 p = 0.88 at 18 months not significant African American patients had better emotional functioning p = 0.0335* Singh, 2013, Pre-operative education (N = 72, Intervention n = 41) FACT-B 105.42 (18.3) Change 1.92 (16.21) p = 0.43 DASH 18.3 (18.7) Change 4.76 (16.65) p = 0.27 Cho, 2012, Pre-and post-operative education (N = 145, Intervention n = 58) Arm Circumference p = 0.0097* Postmastectomy Activity Scale p ≤ 0.0001* 4.34 (95% CI 4.21–4.49 T1 T2 − 5.12 (95%CI: 4.91–5.34) Adherence to wearing the gown and increased exercise p = 0.039* Koelmeyer, 2020, Post-operative education (N = 20, Intervention n = 20) L-Dex (> + 6.5 defines as lymphedema) 25% had an increase of >  + 6.5 in 3 months Lymphedema Symptom, Intensity and Distress Survey Arm version Decreased by 0.4 out of 10.0 (95%CI 0.1 to 0.7) over 6 months p < 0.05* Incidental and planned Exercise Questionnaire No increase in total Physical activity but there was an increase of 2.8 h per week (95% CI 0.4 to 5.2) p < 0.05* of planned exercise over 6 months Zhang, 2020, Post-operative education (N = 85, Intervention n = 43) Chinese version FACT-B Significant at 3 months p < 0.05 * Lu, 2015, Post-operative education (N = 1217, Intervention n = 672) Cansiz, 2021, Education for women with BCRL (N = 44, intervention n = 44) Limb volume calculated (p = 0.000)* Bioimpedance L-Dex no final data due to Covid-19 Adaptation to Chronic Illness Scale (p = 0.001)* Patient Activation Measure (p = 0.000)* Katz Index of Independence in Active Daily Living Scale (p = 0.018)* DASH (p = 0.000)* Liu, 2021, Education for women with BCRL (N = 41, intervention n = 40) Limb circumference Significant lower at 4 months follow up p = 0.006* Breast cancer and lymphedema Symptom experience index Significant changes in functional, social, emotional, and psychological and self-perception among 5 test points (p ≤ 0.05)* No difference in sleep and sexuality (p > 0.05) Ridner, 2020, Education for women with BCRL (N = 109, Intervention n = 47) Bioimpedance No significant difference Cohen’s d =  + 0.36 LSIDS-A no significant difference in reduction of symptoms effect size = 0.05–0.28; p > 0.05* Quick DASH No statistical difference p > 0.05 Effect size pamphlet group − 0.19 greater increase in function/wellbeing than web-based group + 0.30 Pamphlet group 62 (77.5%) completed their program Web-based multimedia 47 (58.8% completed their program p = 0.011 Web based took longer to do Aringa, 2016, Education for women with BCRL (N = 23) Limb volume (p = 0.01)* Tonometer LYMQOL Discomfort (p = 0.00)* Sensory alternation (p = 0.02)* Swelling (p = 0.02)* Heaviness (p = 0.05)* ULL-27 No significant change Perceived adherence for self-care (p = 0.01)* Self-rated skin condition No significant difference DASH Disability of Arm, Shoulder, and Hand questionnaire, SPOFIA Subject Perception of Post-Operative Functional Impairment of the Arm, LLIS Lymphedema Life impact Scale, FACT B + 4 Functional Assessment of Cancer Therapy Breast + Arm Morbidity Subscale, LSIDS-A Lymphedema Symptom and Distress Scale- Arm, BCRL breast cancer–related lymphedema, yr year, OR odds ratio, CI confidence interval, LE lymphedema *Significant Cho (2012) developed a 10-item investigator-designed questionnaire to assess participant knowledge about BC care [24]. The results indicated significantly higher knowledge scores for those who had education 0.36 (95% CI 0.30 − 0.40) compared to no education 0.11 (95% CI 0.07–0.15 p = 0.0001). Overall, the results of these outcome measures could only infer that BCRL education played a role in improvements of quality of life, function, adherence to self-care practices, and early identification of lymphedema [17–20, 26]. Unfortunately, knowledge acquisition was not directly assessed in any of these studies.

Discussion/Summary

Based on the evidence appraised, this systematic review was unable to determine the optimal content, mode, and timing for BCRL education across survivorship. The BCRL educational content most consistently taught included definition of lymphedema, risk reduction practices, early signs and symptoms, and self-care management. Several low-quality studies in this review provided this information using previously developed BCRL educational material by the American Cancer Society Guidelines for Lymphedema, National Lymphedema Network, or Australian Cancer Council Lymphedema FACT Sheet [21, 22, 25, 28]. This information varies widely in depth and breadth but provides a general overview of BCRL physiology, pathophysiology, risk reduction practices, and interventions. These organizations provide an educational starting point for clinicians and survivors; however, universal guidelines for BCRL educational content do not exist. Most importantly, BCRL education should be individualized based on the survivors’ needs and preferred learning styles. The educational session may be influenced by the phase and intensity of an individuals’ cancer treatment plan, and therefore, the health care educator may adjust volume and content accordingly. Presently, healthcare providers independently determine what content to include, how to provide the education, and when to deliver it. Future research is needed to develop evidence-based BCRL recommendations on educational content, mode of delivery, and its timing. Knowledge and retention assessment was not a primary or secondary aim of the reviewed studies. To determine effectiveness of BCRL education delivery, repetition and follow up of BCRL education over time may be needed for an individual to acquire and retain knowledge. Retention of knowledge and follow up with health care professionals may enhance early detection and treatment of BCRL [11]. Further research to assess the individuals’ knowledge acquisition, understanding, and integration of the information received and the value of repeating education over time throughout survivorship are needed. In the studies reviewed, psychosocial issues regarding the impact of BCRL education timing and volume of information provided were not assessed or discussed. Individuals diagnosed with BC may experience different treatment regiments throughout the trajectory of care, which results in varying demands and stresses. Additionally, it is well known that cancer treatments, especially chemotherapy, can lead to cancer-related fatigue and cognitive impairments that can influence knowledge acquisition [33, 34]. The negative impact of psychosocial issues across survivorship may influence the content, mode, and optimal timing of BCRL education. When developing BCRL education, healthcare professionals may consider balancing the volume of material, the time commitment required, and the individual’s mental health [33]. Studies also reported that individuals have preferred learning styles; therefore, a multi-modal approach to BCRL education is indicated [12]. Healthcare professionals should ask individuals how they would like to receive the education. For example, some individuals prefer web-based education while others prefer one-on-one or in-person group education [12, 35]. Additionally, some individuals prefer the option of reading booklets and handouts prior to discussion [12, 35]. Finally, in these studies, the age of most participants ranged from 47 to 61 years. As age may influence the preference of delivery modes, it will need to be a consideration when designing a BCRL educational program. Further research is needed to explore all the factors contributing to an individual’s ability to acquire knowledge.

Limitations

An overall limitation to this systematic review is the wide variability in methodology. Timing of BCRL education occurred pre/post operatively, or once BCRL developed. Content and volume of BCRL education varied across trajectory of BC care. Knowledge assessment and repetition of education was rarely included in the studies. Additionally, this systematic review included only English language publications from January 1, 2011 to December 31, 2021, which may have limited the authors’ findings. Participant characteristics reflected a wide range of demographics and risk factors, which may influence the content, mode of delivery, timing of education, and total time required to deliver the patient education.

Impact for breast cancer health care professionals and survivors of breast cancer

Conclusion

Based on this systematic review, evidence suggests BCRL education should be provided at multiple time points along the trajectory of care, with varying depth and breadth of content, and be provided via a multi-modal approach. The BC healthcare team should assess the survivors’ BCRL knowledge and its acquisition and reinforce BCRL education appropriately. Education for individuals diagnosed with BC, at a minimum, should include a brief overview of BCRL, early signs and symptoms, a point of contact for questions, and early referral for intervention. Survivors, who are at high risk for developing BCRL, may need a more detailed educational approach emphasizing individualized risk reduction practices. Interventions for individuals with BCRL require a strong focus on self-management and self-efficacy. Future research needs to determine the most appropriate educational content, mode, time point, and follow up for providing BCRL education across the trajectory of survivorship.
  30 in total

1.  The effect of prospective monitoring and early physiotherapy intervention on arm morbidity following surgery for breast cancer: a pilot study.

Authors:  Chiara Singh; Mary De Vera; Kristin L Campbell
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

2.  Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life.

Authors:  Sheila H Ridner; Mary S Dietrich; Nancy Kidd
Journal:  Support Care Cancer       Date:  2011-05       Impact factor: 3.603

3.  The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.

Authors:  Atilla Soran; Tolga Ozmen; Kandace P McGuire; Emilia J Diego; Priscilla F McAuliffe; Marguerite Bonaventura; Gretchen M Ahrendt; Lori DeGore; Ronald Johnson
Journal:  Lymphat Res Biol       Date:  2014-12       Impact factor: 2.589

4.  A 10 Minute Self-Care Program May Reduce Breast Cancer-Related Lymphedema: A Six-Month Prospective Longitudinal Comparative Study.

Authors:  Y Arinaga; F Sato; N Piller; T Kakamu; K Kikuchi; T Ohtake; A Sakuyama; F Yotsumoto; T Hori; N Sato
Journal:  Lymphology       Date:  2016-06       Impact factor: 1.286

5.  Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.

Authors:  Ya-Chen Tina Shih; Ying Xu; Janice N Cormier; Sharon Giordano; Sheila H Ridner; Thomas A Buchholz; George H Perkins; Linda S Elting
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

6.  Role of physiotherapy and patient education in lymphedema control following breast cancer surgery.

Authors:  Shiang-Ru Lu; Rong-Bin Hong; Willy Chou; Pei-Chi Hsiao
Journal:  Ther Clin Risk Manag       Date:  2015-02-25       Impact factor: 2.423

7.  "I never heard anything about it": Knowledge and psychosocial needs of Latina breast cancer survivors with lymphedema.

Authors:  Lydia P Buki; Zully A Rivera-Ramos; Marlen Kanagui-Muñoz; Puncky P Heppner; Lizette Ojeda; Emaan N Lehardy; Kari A Weiterschan
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

8.  Effect of lymphedema self-management group-based education compared with social network-based education on quality of life and fear of cancer recurrence in women with breast cancer: a randomized controlled clinical trial.

Authors:  Zahra Omidi; Masoomeh Kheirkhah; Jamileh Abolghasemi; Shahpar Haghighat
Journal:  Qual Life Res       Date:  2020-03-09       Impact factor: 4.147

9.  Informational Needs in Patients With Breast Cancer With Lymphedema: Is It Important?

Authors:  Sara Dorri; Asiie Olfatbakhsh; Farkhondeh Asadi
Journal:  Breast Cancer (Auckl)       Date:  2020-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.